Global Topical Pain Management Therapeutics In Sports Medicine Market Size, Share, Forecast Report, 2020-2027

The global Topical Pain Management Therapeutics in Sports Medicine market garnered revenue around USD 1,622.6 Million in 2019 and projected to reach USD 3,471.2 Million in 2027, with at a compound annual growth rate (CAGR) 8.7% throughout the estimate period from 2020 to 2027.

The medicine or drugs which are applied locally on the area which is being treated is called as topical drugs. ‘Topikos’ in Greek means ‘at a place’. Many creams and ointments which are applied to skin are often called a topical drugs. Topical pain management therapeutics are specialty products that are used to relieve acute musculoskeletal pain or general sprains or strains.

The therapeutics involve various drug classes such as analgesics, anesthetics, and skeletal muscle relaxants. Topical pain relievers are becoming increasingly popular in sports category owing to their site-specific action, cost-effectiveness, instant pain relief, and availability in the OTC segment.

North America dominated the global topical pain management therapeutics in sports medicine market in 2019 and the trend is anticipated to continue during the forecast period. Innovative product launches such as fast relief gels and patches, increase in implementation of guidelines implemented by various health care organizations promoting the use of topical medications over oral medications for pain management in the U.S. are expected to drive the market in North America. Asia Pacific is likely to be a highly lucrative market for topical pain management therapeutics and it is expected to expand at a high CAGR during the forecast period

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Topical Pain Management Therapeutics in Sports Medicine market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Topical Pain Management Therapeutics in Sports Medicine market growth.

The global Topical Pain Management Therapeutics in Sports Medicine market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

the global market include Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Hisamitsu Pharmaceutical Co., Inc., Mayne Pharma Group Limited, Chattem, Inc., GlaxoSmithKline plc, Endo Pharmaceuticals Inc., Beiersdorf AG, Johnson & Johnson Services, Inc. and Topical BioMedics, Inc.

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

Global Topical Pain Management Therapeutics in Sports Medicine Market, by Product

  • Gels
  • Creams
  • Sprays
  • Patches
    • Drug in Adhesives
    • Matrix
    • Reservoirs
    • Others

Global Topical Pain Management Therapeutics in Sports Medicine Market, by Therapeutic Class

  • Analgesics
    • Opioids
      • Fentanyl
      • Buprenorphine
      • Others
    • Non-opioids
      • Lidocaine
      • Diclofenac
      • Capsaicin
      • Methyl Salicylate
      • Others
    • Anesthetics
    • Skeletal Muscle Relaxants

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Rest of EU
  • Asia Pacific
    • China
    • India
    • Japan
    • Southeast Asia
    • Rest of APAC
  • Central & South America
    • Brazil
    • Argentina
    • Rest of Central & South America
  • Middle East and Africa
    • UAE
    • Saudi Arabia
    • Rest of MEA